Background: Bioactivity-guided fractionation of extracts of Aglaia loheri Blanco (Meliaceae) yielded a cytotoxic isolate, termed Maldi 531.2 [M + H] + . This phenolic ester was further investigated for its in vitro cytotoxicity toward human CCRF-CEM leukemia cells and their multi-drug resistant (MDR) subline, CEM/ADR5000. The intrinsic mitochondrial membrane potential (ΔΨm) and induction of apoptosis by this isolate were evaluated.
Background
Hematologic malignancies account for a considerable percentage of cancers worldwide [1] . A common type of this malignancy is acute lymphoblastic leukemia (ALL). ALL involves rapid transformation of a single normal progenitor cell [2] triggered by several factors associated with exposure to radiation and chemicals. These factors cause genetic damage, resulting in complete destruction of cellular regulatory controls on proliferation, differentiation and apoptosis [3] [4] [5] [6] . Since leukemia is a systemic disease, its cure depends on chemotherapy [7] rather than surgery. A new approach to increasing effectiveness to chemotherapy includes the use of various molecularly targeted drugs derived from natural plant products [8] .
The research on Aglaia loheri was part of a larger project to explore the potential medicinal value of plants endemic to the mountain area of Kanawan, Morong (Bataan, Philippines) which is part of the ancestral domain of indigenous people called Aetas. From personal communications with the indigenous people, it was learned that some of the plants were used by the Aetas for medicinal or nutritional purposes. A. loheri is actually part of their diet. However, due to accounts from published literature on other Aglaia species, we hypothesized that A. loheri may be cytotoxic towards cancer cells.
The genus Aglaia (family Meliaceae) is an important source of unique bioactive natural products, which contain a cyclopenta [b] tetrahydrobenzofuran skeleton and include more than 50 naturally occurring derivatives collectively called rocaglamides [9] . This group of compounds was found to be effective against thymidine kinasedeficient Herpes simplex virus type 1 (HSV-1) and phosphonoacetate-resistant HSV-1 strains [9] , including human amoebiasis caused by Entamoeba histolytica [10] . These compounds were shown to inhibit necrosis factor (NF)-B induced gene activation in human T cells [11] , HIV-1 infection [12] , and initiation and promotion of chemically-induced cancer on mouse skin [13] . Amide esters are structurally related to bisamides and flavaglines from Aglaia sp. [14] and exhibited anti-fungal [15] , insecticidal [16] , anti-tuberculosis and anti-viral activities [17] . Remarkably, this class of compounds also induces apoptosis in resistant human cancer cells [18] [19] [20] . For example, silvestrol, a novel compound from Aglaia was active against cancer cells in vitro and in vivo [20, 21] . It induced apoptosis in prostate carcinoma cells through the mitochondrial/apoptosome pathway without activation of caspase-3 or −7 [19] and in human B-leukemia cells, by reducing Mcl-1 expression due to inhibition of translation with subsequent mitochondrial damage [21] .
In the present study, crude extracts from leaves of A. loheri Blanco were subjected to bioassay-guided isolation by means of various chromatography techniques. The resulting active principle was further analyzed and characterized by mass spectroscopy and nuclear magnetic resonance (NMR). The isolated active principle was investigated for its cytotoxicity towards cancer cells. The mitochondrial membrane potential (ΔΨ m ) was analyzed as a key indicator of cell viability [22, 23] and induction of apoptosis as an important parameter of cell integrity.
Methods

Kits and reagents
Analytical grade ethyl acetate and hexane were used for extraction. Analytical grade chloroform and methanol were used for gravity column chromatography. Silica gel 60 G 0.063-0.200 mm (Merck; Germany) was used for gravity column chromatography. Pre-coated gel 60 G F 254 plates 0.25 mm thick (Merck, Darmstadt, Germany) were used for thin layer chromatography (TLC). Iodine crystals and UV were used to visualize separation monitored by analytical TLC. Doxorubicin was purchased from Sigma Chemical Company, USA. Dimethyl sulphoxide (DMSO) (Sigma, St. Louis, MO, USA) was used to dissolve the test samples. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Promega, USA. XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide), XTT labelling reagent (sodium 3'-[1-phenylaminocarbonyl)-3,4-tetrazolium]-bis (4-methoxy-6-nitro) benzene sulfonic acid hydrate) and electron-coupling reagent (N-methyl dibenzopyrazine methyl sulphate [0.383 mg/mL (1.25 mM)] in sterile phosphate buffered saline (PBS) were purchased from Roche (Mannheim, Germany). JC-1 and annexin V-FITC detection kit was obtained from eBioscience (Frankfurt, Germany); propidium iodide and carbonyl cyanide 3-chlorophenylhydrazone (CCCP) from Sigma-Aldrich (Taufkirchen, Germany).
Cell culture and supplements
Human colon cancer cell line (HCT116) was obtained from American Type Culture Collection (ATCC, Manassas, Virginia, USA). The cells were grown in McCoy's 5a modified medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% inactivated fetal bovine serum (Invitrogen, USA) and 1% penicillin-streptomycin (100 U/mL) (Invitrogen, USA). The cell line was maintained in a humidified incubator containing 5% CO 2 at 37°C.
Human leukemic cells, CCRF-CEM and their multidrug-resistant subline, CEM/ADR5000 [24] , were obtained from Dr. Axel Sauerbrey (Department of Pediatrics, University of Jena, Germany). The cells were maintained in a humidified environment at 37°C and 5% CO 2 . The cells were grown in RPMI 1640 [−] L-glutamine containing 1% penicillin (10 U/mL), streptomycin 10 μg/mL, and 10% heat-inactivated fetal bovine serum (FBS) (all obtained from Gibco Invitrogen, Germany). Drug resistance of of CEM/ADR5000 cells was maintained by weekly treatment with 5000 ng/mL. P-glycoprotein expression without overexpression of other ATP-binding cassette transporters in CEM/ADR5000 cells has been reported [25, 26] .
Peripheral blood mononuclear cells (PBMC) were isolated from freshly collected whole blood sample using Ficoll-paque solution (Histopaque-1077) (Sigma) by centrifugation [27] . The cells were washed twice with RPMI-1640 and were re-suspended in same culture medium (RPMI-1640). Cells (0.5 mL of cell suspension) were seeded in a 24-well sterile plate at a density of 10 6 /mL prior to activation with 0.5 mL of 10 μg/mL of phytohemagglutinin (PHA). Addition of 0.5 mL of PHA into each well (0.5 mL RPMI-1640 to one control group) adjusted the number of cells to a final density of 5 × 10 5 /mL per well. The cells were incubated at 37°C and 5% CO 2 for 3 days prior to XTT assay.
Collection of plant material
Fresh and mature leaves of A. loheri Blanco were collected in the morning from its natural habitat in Morong (Bataan, Philippines). Voucher specimen of the plant under Accession No. 14612 was deposited and authenticated by the Jose Vera Santos Herbarium of the Institute of Biology, University of the Philippines (Diliman, Quezon City, Philippines). The leaf specimens were washed and air-dried in a well-ventilated room at Pavilion IV, Institute of Biology, University of the Philippines (Diliman, Quezon City, Philippines). After drying, the leaf samples were homogenized using a blender.
Concentration and solvent fractionation
Homogenized leaf samples were soaked in ethanol for 48 h. The soluble ethanolic extract was filtered and the filtrate was concentrated in vacuo at 40°C using a rotary evaporator (Heidolph, Schwabach, Germany) yielding a concentrated ethanolic crude extract (ECE). ECE was assayed for cytotoxicity by using MTT assay [28] against HCT116 cells. The concentrated ECE was diluted in approximately 200 mL ethanol and was partitioned exhaustively with hexane and ethyl acetate successively. Both hexane soluble extract and ethyl acetate soluble extract were concentrated in vacuo at 40°C separately which yielded concentrated hexane extract (HE) and concentrated ethyl acetate extract (EAE). Finally, the two concentrated crude fractions were tested for their cytotoxicity by the MTT assay.
Determination of band profiles by thin layer chromatography (TLC)
A small amount of the EAE was spotted 5 cm above the bottom edge of the 5 × 7.5 cm TLC plate using a very thin glass tube. The extract was air-dried on the TLC plate which was then placed in eluent in the developing chamber so the bottom of the plate is in the liquid. Several eluents with increasing/decreasing concentration ratio (ranging from 1:9 to 9:1) of chloroform to methanol were prepared to determine the best solvent system that separates components of the mixture in the extract; the 9:1 chloroform-methanol was used as solvent system in column chromatography.
Gravity column chromatography
EAE was fractionated using gravity column chromatography. The glass column was packed with Silica gel Merck® grade 9385, pore size 60 Å, 230-400 mesh. A 9:1 chloroform-methanol was used as an eluting solvent in the first batch of fractionation to produce column fractions (CF). Increasing gradient concentrations of hexane and ethyl acetate were used in the next batch to produce sub-fractions (SF). An appropriate amount of extract was applied to the top of the column to prevent overloading: 1.0 g of extract to 1 kg of silica gel was packed in the glass column. The eluates (20 mL) were collected in test tubes and separation was monitored by TLC. Those eluates with same TLC profiles were pooled together, concentrated in a rotary evaporator and labeled as chromatographic fractions (CF). TLC profiles of the eluates were visualized by using UV light (100 nm -315 nm) to detect the presence of aromatic compounds and 10% vanillin-sulfuric acid as spray reagent to detect groups of unsaturated compounds on the TLC plate. Pooled fractions were then subjected to MTT assay. Fractions that showed the highest cytotoxic activity were further fractionated in gravity column chromatography (2 cm in diameter and 37 cm long) through gradient elution. An active isolate was finally purified by high performance liquid chromatography (HPLC) using Silica-C18 as packing material and methanol-water as the mobile phase and was submitted for mass spectrometry to determine the molecular weight and nuclear magnetic resonance (NMR) analysis to determine the possible structure of the compound.
Cell viability assays
To determine the cytotoxic effects of the crude extract and isolated compound, cellular growth of both untreated and treated cells was monitored using the MTT (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay [28] . A master dilution plate (MDP) was prepared before subjecting the cells to MTT assay. Each MDP contained A. loheri extracts/isolate in varying concentrations ranging from 125-1000 μg × mL -1 for crude extracts and 7.8-62.5 μg × mL -1 for pure isolates. Cells were harvested and seeded in a sterile, flat-bottom 96-well microtiter plates at a density of 3.5 × 10 5 mL
, then were incubated for 24 h at 37°C in a humidified incubator with 5% CO 2 . After 24 h incubation, 10 μL from MDP preparation were added to the cells in each well to make final concentrations of 50, 25, 12.5 and 6.25 μg × mL -1 for crude extracts and 7.8, 15.6, 31.25, 62.5 μg × mL -1 for the pure isolate. The cells were then incubated for 72 h. After incubation, the media was discarded, and 20 mL of MTT were added to each well. The MTT solution was made by dissolving 5 mg MTT (Sigma-Aldrich) per mL phosphate buffer solution. The cells were again incubated for 4 h before adding 150 mL of DMSO (Sigma, USA) to dissolve the formazan crystals. At least two independent tests with three replicates each were performed in this experiment. The absorbance of the formazan crystals was then taken with dual wave-measurement at 570 nm and 620 nm using a Bio-Rad microplate reader (Munich, Germany).
Furthermore, a colorimetric XTT-based assay was applied according to the manufacturer's protocol. Two independent tests were conducted. Cells grown in cell culture flasks were harvested. A 100 μL aliquot of 2.0 × 10 5 cells/mL were seeded into each well of a 96-well microtiter cell culture plate, and were immediately treated with various concentrations (0.001 to 30 μM) + required to inhibit growth of 50% of the incubated cell population.
Mitochondrial membrane potential (ΔΨm) analysis
JC-1 is a membrane permeable dye that selectively accumulates in the mitochondria, where it reversibly changes color as membrane potential (ΔΨm) increases over values of about 80-100 mV. JC-1 is widely used for quantifying mitochondrial membrane potential by measuring the fluorescence intensities and is therefore an indicator of initiation of cell apoptosis [30] . To assess the effect of Maldi 531. 2 
[M + H]
+ on ΔΨm, 10 6 cells were incubated for 24 and 48 h (37°C, 5% CO 2 ) with three doses (0.05, 0.5 and 1.0 μM). Two aliquots of cells were treated with the control drugs: 10 μg/mL doxorubicin and 0.05 μM CCCP (Sigma-Aldrich) and incubated at 37°C and 5% CO 2 . An incubation time of 10 min was sufficient, because of the rapid stimulation of membrane polarization by CCCP. An incubation of more than 10 min with CCCP greatly reduces the fluorescence intensity in the FL2 channel (564-606 nm) converting a red fluorescence signal to a green signal. Afterwards, the cells were stained with JC-1 for 30 min at 37°C and 5% CO 2 . The membrane sensitive JC-1 dye was prepared according to the manufacturer's recommended concentration of 2.5 μg/million cells/mL from a stock solution of 1 mg/mL prior to use (eBioscience, Germany). The dye was pre-warmed in a 37°C water bath prior to addition to treated and untreated cells. . Annexins are calcium-dependent, phospholipid-binding proteins that specifically bind to phosphatidylserine (PS) in the plasma membrane [31] . Under normal physiological conditions, PS is predominantly located in the cytosolic layer of the plasma membrane. Upon initiation of apoptosis, PS is translocated from the cytosolic layer of the plasma membrane to the extracellular layer for recognition and uptake by phagocytes, where it can be detected by fluorescently-labeled Annexin V (eBioScience). Cells were exposed to the active isolate (0.05, 0.5, 1.0 μM) and incubated for 24 h at 37°C and 5% CO 2 . For positive controls, cells were treated with 10 μg/mL doxorubicin (Sigma-Aldrich) and 10 μM camptothecin separately and were also incubated for 24 h at 37°C and 5% CO 2 . The annexin-V assay was performed according to the protocol provided in the annexin V-FITC detection kit (eBioScience). Briefly, 5.0 × 10 5 treated cells were resuspended in 50 μL of 1× annexin-staining buffer containing 10 mM HEPES, 140 mM NaCl, and 2.5 mM CaCl 2 (pH 7.4) and incubated in the dark with 2.5 μL of annexin V conjugate for 15 min at 25°C. After incubation, the final volume of each sample was adjusted to 500 μL followed by the addition of 1.25 μL of 1 mg × mL -1 propidium iodide (PI). Apoptotic cells were analyzed using a FACS®Calibur (Becton Dickinson, Heidelberg, Germany) and CellQuest Pro (Becton Dickinson) analysis software. Excitation and emission settings were 488 nm, 515-545 nm (FL1 channel) for annexin V-FITC and 564-606 nm (FL2 channel) for PI.
Statistical analysis
Data were expressed as mean ± SEM of two independent tests. JC-1 and annexin V-FITC fluorescence intensity data were subjected to one-way analysis of variance followed by Tukey's multiple comparison test. A probability of less than or equal to 0.05 was considered statistically significant to reject the null hypothesis.
Results
Bioactivity-guided isolation of an active fraction from A. loheri Approximately 15.23 g (1.96%) of ethyl acetate crude extract were obtained from 777 g of dried ground leaf samples of A. loheri after solvent partitioning. Cytotoxicity of the extracts was tested towards HCT116 by the MTT assay. The ethyl acetate fraction was cytotoxic exhibiting an IC 50 concentration of 5.47 μg/mL. Ethyl acetate extract was subjected to gravity column chromatography utilizing silica gel-60 as stationary phase packed in 3.5 cm diameter, 37 cm long glass column, and 9:1 chloroform-methanol as mobile phase. This chromatographic separation yielded 10 column fractions, where CF1 revealed the highest cytotoxicity (IC 50 of 3.82 ± 0.02 μg/mL). For comparison, doxorubicin was used as control drug and revealed an IC 50 of 3.74 ± 0.14 ( Table 1) . Further gradient fractionation of CF1 yielded 11 sub-fractions (SF) whose IC 50 values are shown in Table 2 . SF9 was the most cytotoxic one. Therefore, this fraction was subjected to HPLC to further purify the active compound. Four distinct peaks were generated. The eluates collected from peaks 1, 2 and 3 were colorless while peak 4 was greenish in color. Cell viability test results after cytotoxicity assay are shown in Table 3 .
Chemical characterization of the bioactive A. loheri fraction
Bioactivity-guided fractionation of a crude extract of A. loheri leaves led to the isolation of a bioactive component (peak 3), an amorphous white powder of approximately 2.0 mg (total yield = 1.3%) which exhibited a molecular ion peak at m/z 531. 2 cells [32] . Maldi 531.2[M + H] + was also tested against HCT 116 cells yielding a mean IC 50 of 3.9 μg/mL (data not shown). However, an MDR suspension cell line and its corresponding sensitive line, were used for the later experiment due to the ease of maintaining and handling suspension cell line over that of adherent cell line which need constant trypsinization. Although it is important that the cytotoxic agent be determined to be specific only to cancer cells, it is an established fact that many of the presently used cancer chemotherapeutic agents are not specific against tumor/ malignant cells only. They also affect fast dividing normal cells such as those in the blood, in the digestive tract and other organs leading to a number of side effects like vomiting, hair loss, and the like. Hence, a number of studies that seek to mitigate these effects on normal cells such as on drug delivery specifically targeting cancer cells are being actively explored. We also suggest this as an offshoot of this study as part of the recommendation or future directions or follow up studies.
In connection with this, a cell viability test was performed separately using PHA-activated peripheral blood mononuclear cells (PBMC Figure 3 . However, despite its cytotoxic effects on PBMC, the level of toxicity is much less than its effects toward CCRF-CEM and ADR5000/CEM cells. + reduced the occurrence of early apoptotic, but not late apoptotic and dead cells over time.
Quantitation of intrinsic mitochondrial membrane potential by flow cytometry
Discussion
Plant extracts usually contain many secondary metabolites with varying bioactivities [33] . In the present investigation, we report the isolation of a cytotoxic component of A. loheri, termed Maldi 531.2[M + H] + . The cytotoxic properties of genus Aglaia was previously recognized by several groups [34] . Therefore, chemical studies of the constituents of Aglaia focused primarily on its toxic components resulting in the structure elucidation of numerous phytochemical compounds [34] . To date, Aglaia still represents a promising and rich source for novel compounds. The isolation and purification of Maldi 531. 2 
[M + H]
+ from A. loheri proved to be difficult, because the isolated active component, was only present in very low amounts. Despite this limitation, we were able to investigate the bioactivity of Maldi 531.2[M + H] + towards cancer cells. Based on mass spectrometry analyses, this compound does not reveal any similarity with other compounds isolated from other Aglaia species [19, 20] . As shown in Tables 5 and 6 , the molecular ion peaks of other Aglaia compounds are distinct from that of our A. loheri isolate with m/z 531.2[M + H] + , indicating that this represents a still unknown compound at least for the genus Aglaia.
The isolate could possibly be related to bisamides and flavaglines isolated by Kim et al. [19] and Salim et al. [20] based on their cytotoxic and anticancer activities. Cytotoxic activities were also observed in other isolated compounds from A. tenuicaulis and A. forbesii such as amide esters [14, 17] , which also demonstrated bioactivity, e.g. anti-inflammatory and antimicrobial [35] , antiviral [17] , and anticancer activities [36] .
Phenolic esters inhibit carcinogenesis and reduce progression of cancer. Understanding the molecular basis of their anticancer properties based on structure and activity is important for the rational design of novel chemotherapeutic agent [37] . Maldi 531.
2[M + H]
+ is a phenolic derivative. Structure, lipophilicity and antioxidant properties of the compounds are major factors affecting the cytotoxicity of the compound due to the presence of a number of hydroxyl (−OH) ring components and by the length of the alkyl esters within the structure [37] . Lipophilicity goes with the number of alkyl esters, i.e. the longer the alkyl esters in the molecule, the greater its anticancer effect [37] . For example, propyl esters are more effective against tumor cells than methyl esters. In addition, -OH groups are responsible for the antioxidant property in phenolic compounds and their methylation diminishes their cytotoxicity [38] . However, lipophilicity and antitumor activity were difficult to correlate, because other structural characteristics may also account for the cytotoxicity of Apoptosis is a fundamental, energy-dependent biological mechanism [31, 39] , which can be triggered by a diverse array of stimuli, including phytochemicals [40, 41] . The reduction of ΔΨm by Maldi 531.2[M + H] + in the present study strongly indicates initiation of apoptotic events and inhibition of cell proliferation by dissipation of the mitochondrial membrane potential. Mitochondria are dynamic organelles, as they constantly produce ATP [42] . A decrease of the mitochondrial membrane potential results in loss of mitochondrial function as it is an important component of the electrochemical gradient that is generated across the inner mitochondrial membrane during electron transport and oxidative phosphorylation [43] . Thus, ΔΨm is used as an indicator of cell integrity [23] , which is critical for normal function of mammalian cells, maintaining the function of mitochondrial proteins in the production of ATP and reactive oxygen species (ROS). Alterations of the mitochondrial membrane potential are indicative of changes in mitochondrial metabolic activity (Acton 2004) leading to cell cycle arrest and apoptosis [44] .
Two biochemical assays were used to establish apoptosis: annexin V and JC-1 mitochondrial membrane potential assay. The results of these two assays are sufficient to establish the occurrence of apoptosis. JC-1 assay evaluates extent of apoptosis through an end point which is the loss of the mitochondrial membrane potential reflected by the entry and aggregation of the dye inside the mitochondrial matrix. This event presupposes that cytochrome C has been released, an event associated with the loss of the mitochondrial membrane potential. These two events however may not always go together since it has been shown that loss of mitochondrial membrane potential is not necessarily required for cytochrome c release [45] .
In the case of the cytotoxicity effect of Maldi 531. -known compound; * -similar to compound 2; ** -almost identical to compound 5; *** -similar to compound 8. to detect PS exposure on the membranes of apoptotic cells with high affinity. Annexin V binding assay detects apoptotic cells significantly even earlier than detections based on alteration in gross DNA structures [31] . Although huge efforts have been undertaken to identify P-glycoprotein inhibitors to overcome multidrug resistance [46, 47] , clinical trials failed as yet [47, 48] . Another concept is to use non-cross-resistant cytotoxic compounds to kill multidrug-resistant tumors. Remarkably, CEM/ADR5000 cells did not reveal considerable cross-resistance to Maldi 531.2[M + H] + (1.5-fold), although CEM/ADR5000 cells were highly resistant to anthracyclines, Vinca alkaloids, taxanes and other established drugs as previously reported [32] . This is a remarkable result, since it implies that Maldi 531. 2 
[M + H]
+ might be suitable to kill refractory tumors, which are resistant to standard chemotherapy.
Conclusion
In conclusion, Maldi 531. 
